Details here.
To accelerate the development and deployment of rapid tests, New York City Economic Development Corporation (NYCEDC), on behalf of the City, is seeking to identify companies developing innovative molecular or antigen rapid tests that can deliver results quickly, reliably, and at scale. Diagnostic test manufacturers, suppliers, developers, and academics are invited to submit proposals by Oct. 14.